A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia
- PMID: 25946358
- PMCID: PMC4562278
- DOI: 10.5588/ijtld.14.0867
A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia
Abstract
Few studies have directly compared the performance of rapid molecular diagnostic tests for tuberculosis (TB). We found that the commercially available molecular diagnostic tests Xpert(®) MTB/RIF and GenoType(®) MTBDRplus both provided timely and accurate results compared to conventional phenotypic tests in detecting TB and rifampicin resistance.
Figures
References
-
- Chiang CY, Van Weezenbeek C, Mori T, Enarson DA. Challenges to the global Control of tuberculosis. J Respirology. 2013;18:596–604. - PubMed
-
- Tukvadze N, Kempker RR, Kalandadze I, Kurbatova E, Leonard MK, Aspindzelashvili R, Bablishvili N, Kipiani M, Blumber HM. Use of a molecular diagnostic test in AFB smear-positive tuberculosis suspects greatly reduces time to detection of multidrug-resistant tuberculosis. PLOS ONE. 2012;7:e31563. - PMC - PubMed
-
- LPA, MTBDRplus. Hain Lifesciences; Nehren, Germany: http://www.ipaqt.org/wp-content/uploads/2013/02/MTBDRplusV2_product-inse....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources